Cytori reports improved skin healing in pivotal burn preclinical study
from Globe Newswire
Cytori Therapeutics, Inc. announced the publication of preclinical data from a study using intravenous delivery of Cytori Cell Therapy™ in a model of large burn injury representative of patients being recruited in the ongoing RELIEF clinical trial. This study was performed with support from the Biomedical Advanced Research and Development Authority (BARDA) as a component of the preclinical data supporting the FDA approved United States RELIEF Trial.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063